Today: 29 January 2026
Subscribe
Browse Category

NASDAQ:NTLA News 2 January 2026 - 9 January 2026

CRISPR Therapeutics stock slides after CFO share-sale filing; JPM conference next

CRISPR Therapeutics stock slides after CFO share-sale filing; JPM conference next

New York, Jan 9, 2026, 15:11 EST — Regular session CRISPR Therapeutics AG shares slid on Friday, bucking a firmer broader market, after a regulatory filing flagged a chief financial officer’s share sale under a pre-arranged trading plan. (Reuters) The company’s CFO, Raju Prasad, exercised stock options for 29,700 common shares and sold 29,700 shares the same day at prices…
9 January 2026
········
CRISPR Therapeutics stock (CRSP) slips into 2026 as New Year’s Day shuts Wall Street — what investors watch next

CRISPR Therapeutics stock (CRSP) slips into 2026 as New Year’s Day shuts Wall Street — what investors watch next

NEW YORK, January 1, 2026, 18:59 ET — Market closed Shares of CRISPR Therapeutics AG ended the last trading session of 2025 down 1.4% at $52.44. U.S. stock markets were closed on Thursday for New Year’s Day, according to the NYSE holiday calendar. StockAnalysis The pullback matters because CRISPR heads into 2026 with its first commercial product still early in…
2 January 2026
········

Stock Market Today

  • Apple Q1 Earnings Preview: iPhone Sales, AI, and Rising Memory Costs Under Scrutiny
    January 29, 2026, 1:58 PM EST. Apple is set to report its fiscal first-quarter earnings Thursday after the bell, with Wall Street expecting EPS of $2.67 and revenue near $138.48 billion. The quarter marks the first full cycle for iPhone 17 sales, with Apple projecting 10-12% revenue growth driven by strong iPhone demand during the holiday season. However, shares have dropped about 11% since early December. Analysts will focus on Apple's management outlook on escalating memory and storage component costs, linked to an AI-driven shortage, which could pressure operating margins. CFO Kevan Parekh downplayed memory cost impact earlier, but Morgan Stanley warns these expenses may become more significant. CEO Tim Cook is likely to face questions on Apple's AI strategy including its use of Google's Gemini and plans for an upgraded Siri, even as AI's commercial benefits remain uncertain amid rising memory prices.
Go toTop